STOCK TITAN

SUPN insider sale notice: 8,588 shares by option exercise on 09/30/2025

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Form 144 filing for SUPN reports a proposed sale of 8,588 shares of common stock to be executed through Morgan Stanley Smith Barney LLC on 09/30/2025 on NASDAQ with an aggregate market value of $408,788.80. The filing states these shares were acquired and will be paid for on 09/30/2025 by exercise of stock options from the issuer. The document also lists multiple recent Rule 10b5-1 sales by Jack A. Khattar totaling numerous transactions in August and September 2025, including sales on 09/29/2025, 09/23/2025, 09/22/2025, and earlier dates, each showing amounts and gross proceeds. The filing shows total shares outstanding of 56,073,088, providing context for the size of the proposed sale within the company's capitalization.

Positive

  • None.

Negative

  • None.

Insights

TL;DR: Routine insider option exercise and small proposed sale versus total shares outstanding; appears procedural and compliance-focused.

The filing documents an officer or insider exercising stock options and proposing to sell 8,588 shares valued at $408,788.80 on 09/30/2025 via Morgan Stanley Smith Barney LLC. With 56,073,088 shares outstanding, this block represents a very small percentage of float. The filing also discloses multiple recent 10b5-1 sales by Jack A. Khattar across August–September 2025, indicating scheduled, pre-planned dispositions rather than ad hoc large divestitures. From a market-impact perspective, the size and nature of the transactions suggest limited immediate pricing pressure. This is a routine disclosure required by Rule 144 and contains no operating results or forward-looking items.

TL;DR: Proper Rule 144 notice and 10b5-1 sales shown; disclosure aligns with compliance expectations for insider transactions.

The form includes the required representation that the selling person does not possess undisclosed material adverse information and references adoption of trading plans where applicable. Multiple 10b5-1 sales are itemized with dates and gross proceeds, demonstrating adherence to pre-established plan mechanics. There are no indications in this filing of unusual governance events, acceleration clauses, or extraordinary insider transfers. The filing serves its compliance purpose but does not provide information on motives, compensation arrangements, or broader governance implications beyond standard insider sales reporting.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the SUPN Form 144 propose to sell?

The notice proposes sale of 8,588 common shares with an aggregate market value of $408,788.80 to be sold on 09/30/2025 on NASDAQ through Morgan Stanley Smith Barney LLC.

How were the 8,588 shares acquired according to the filing?

The filing states the shares were acquired on 09/30/2025 by exercise of stock options from the issuer and payment was made in cash on the same date.

Who has recent 10b5-1 sales disclosed in the filing?

The filing lists multiple 10b5-1 sales for Jack A. Khattar with transactions dated in August and September 2025 and showing amounts and gross proceeds for each sale.

What is SUPN's shares outstanding shown in the filing?

The form reports 56,073,088 shares outstanding, which provides context for the relative size of the proposed sale.

Which broker is handling the proposed sale on Form 144?

The broker named for the proposed sale is Morgan Stanley Smith Barney LLC, 1 New York Plaza, New York, NY.

Does the filing indicate any undisclosed material information?

By signing, the person selling represents they do not know any material adverse information about the issuer that has not been publicly disclosed; the filing contains that certification language.
Supernus Pharma

NASDAQ:SUPN

SUPN Rankings

SUPN Latest News

SUPN Latest SEC Filings

SUPN Stock Data

3.20B
54.86M
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
ROCKVILLE